APP and Alzheimer disease: We therefore imposed ‘negative’ versus ‘positive’ experiences during the early period from postnatal day (PND) 2-9 and analysed whether they differentially influenced AD-related brain changes in transgenic APP.V717I x Tau.P301L (biAT) mice.